CD177 overexpression was significantly correlated with a favorable prognosis for gastric cancer (20) and CD177+ neutrophils suppress epithelial cell tumorigenesis in colitis-associated cancer and predict good prognosis in colorectal cancer (21), pointing to a protective role of CD177 in cancer. The gene discussed is CD177; the disease is gastric cancer.